+ All Categories
Home > Documents > Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes...

Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes...

Date post: 13-Jan-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
30
Diseases of the Liver and Biliary System SHEILA SHERLOCK DBE, FRS MD (Edin.), Hon. DSc (Edin., New York, Yale), Hon. MD (Cambridge, Dublin, Leuven, Lisbon, Mainz, Oslo, Padua, Toronto), Hon. LLD (Aberd.), FRCP, FRCPE, FRACP, Hon. FRCCP, Hon. FRCPI, Hon. FACP Professor of Medicine, Royal Free and University College Medical School University College London, London JAMES DOOLEY BSc, MD, FRCP Reader and Honorary Consultant in Medicine, Royal Free and University College Medical School, University College London, London ELEVENTH EDITION Blackwell Science
Transcript
Page 1: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

Diseases of the Liverand Biliary System

SHEILA SHERLOCKDBE, FRSMD (Edin.), Hon. DSc (Edin., New York, Yale),Hon. MD (Cambridge, Dublin, Leuven, Lisbon,Mainz, Oslo, Padua, Toronto), Hon. LLD (Aberd.),FRCP, FRCPE, FRACP, Hon. FRCCP,Hon. FRCPI, Hon. FACP

Professor of Medicine,Royal Free and University College Medical SchoolUniversity College London,London

JAMES DOOLEYBSc, MD, FRCP

Reader and Honorary Consultant in Medicine,Royal Free and University College Medical School,University College London, London

ELEVENTH EDITION

Blackwell Science

Page 2: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,
Page 3: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

DISEASES OF THE LIVERAND BILIARY SYSTEM

Page 4: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,
Page 5: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

Diseases of the Liverand Biliary System

SHEILA SHERLOCKDBE, FRSMD (Edin.), Hon. DSc (Edin., New York, Yale),Hon. MD (Cambridge, Dublin, Leuven, Lisbon,Mainz, Oslo, Padua, Toronto), Hon. LLD (Aberd.),FRCP, FRCPE, FRACP, Hon. FRCCP,Hon. FRCPI, Hon. FACP

Professor of Medicine,Royal Free and University College Medical SchoolUniversity College London,London

JAMES DOOLEYBSc, MD, FRCP

Reader and Honorary Consultant in Medicine,Royal Free and University College Medical School,University College London, London

ELEVENTH EDITION

Blackwell Science

Page 6: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

© 1963, 1968, 1975, 1981, 1985, 1989, 1993, 1997, 2002 by Blackwell Science Ltd a Blackwell Publishing CompanyEditorial Offices:Osney Mead, Oxford OX2 0EL, UK

Tel: +44 (0)1865 206206108 Cowley Road, Oxford OX4 1JF, UK

Tel: +44 (0)1865 791100Blackwell Publishing USA, 350 Main Street, Malden, MA 02148-5018, USA

Tel: +1 781 388 8250Iowa State Press, a Blackwell Publishing Company, 2121 State Avenue, Ames, Iowa 50014-8300, USA

Tel: + 515 292 0140Blackwell Munksgaard, Nørre Søgade 35, PO Box 2148, Copenhagen, DK-1016, Denmark

Tel: +45 77 33 33 33Blackwell Publishing Asia, 54 University Street, Carlton, Victoria 3053, Australia

Tel: +61 (0)3 9347 0300Blackwell Verlag, Kurfurstendamm 57, 10707 Berlin, Germany

Tel: +49 (0)30 32 79 060Blackwell Publishing, 10 rue Casimir Delavigne, 75006 Paris, France

Tel: +33 1 53 10 33 10

The right of the Author to be identified as the Author of this Work has been asserted inaccordance with the Copyright, Designs and Patents Act 1988.

All rights reserved. No part of this publication may be reproduced, stored in a retrievalsystem, or transmitted, in any form or by any means, electronic, mechanical, photocopying,recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act1988, without the prior permission of the publisher.

The Blackwell Publishing logo is a trade mark of Blackwell Publishing Ltd.

First published 1955Reprinted 1956Second edition 1958Reprinted 1959, 1961Third edition 1963Reprinted 1965, 1966

Fourth edition 1968Reprinted 1969, 1971Fifth edition 1975Sixth edition 1981Reprinted 1982, 1983Seventh edition 1985Reprinted 1986, 1987

Eighth edition 1989Reprinted 1991Ninth edition 1993Reprinted 1993Tenth edition 1997Eleventh edition 2002

Catalogue records for this title are available from the Library of Congress and the BritishLibrary

ISBN 0-632-05582-0

Set in 8/10 pt Palatino by Best-set Typesetter Ltd, Hong KongPrinted and bound in Italy, by Rotolito Lombarda, Milan

For further information on Blackwell Science, visit our website: www.blackwell-science.com

Page 7: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

Preface to the Eleventh Edition, xv

Preface to the First Edition, xvi

1 Anatomy and Function, 1

Functional anatomy: sectors and segments, 2Anatomy of the biliary tract, 3Development of the liver and bile ducts, 4Anatomical abnormalities of the liver, 4Surface marking, 5Methods of examination, 5Hepatic morphology, 6Electron microscopy and hepato-cellular function, 9Sinusoidal cells, 11Hepatocyte death and regeneration, 13Extra-cellular matrix, 14

Altered hepatic microcirculation and disease, 14Adhesion molecules, 14

Functional heterogeneity, 14Sinusoidal membrane traffic, 16

Bile duct epithelial cells, 16

2 Assessment of Liver Function, 19

Selection of biochemical tests, 19Bile pigments, 20

Bilirubin, 20Urobilinogen, 20Bromsulphalein, 21

Serum enzyme tests, 21Alkaline phosphatase, 21Gamma glutamyl transpeptidase, 22Aminotransferases, 22Other serum enzyme, 23

Quantitative assessment of hepatic function, 23Galactose elimination capacity, 23Breath tests, 23Salivary caffeine clearance, 24Lignocaine metabolite formation, 25Arterial blood ketone body ratio, 25Antipyrine, 25Indocyanine green, 25

Asialoglycoprotein receptor, 25Excretory capacity (BSP), 25

Lipid and lipoprotein metabolism, 26Lipids, 26Lipoproteins, 26Changes in liver disease, 27

Bile acids, 28Changes in disease, 29Serum bile acids, 30

Amino acid metabolism, 31Clinical significance, 31

Plasma proteins, 32Electrophoretic pattern of serum proteins, 33

Carbohydrate metabolism, 34Effects of ageing on the liver, 34

3 Biopsy of the Liver, 37

Selection and preparation of the patient, 37Techniques, 37

Difficulties, 40Liver biopsy in paediatrics, 40

Risks and complications, 40Pleurisy and peri-hepatitis, 40Haemorrhage, 40Intra-hepatic haematomas, 41Haemobilia, 41Arteriovenous fistula, 42Biliary peritonitis, 42Puncture of other organs, 43Infection, 43Carcinoid crisis, 43

Sampling variability, 43Naked eye appearances, 43Preparation of the specimen, 43Interpretation, 43Indications, 44Special methods, 44

4 The Haematology of Liver Disease, 47

General features, 47The liver and blood coagulation, 49

Contents

v

Page 8: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

Haemolytic jaundice, 53The liver in haemolytic anaemias, 54

Hereditary spherocytosis, 54Thalassaemia, 55Paroxysmal nocturnal haemoglobinuria, 56Acquired haemolytic anaemia, 56Haemolytic disease of the newborn, 56Incompatible blood transfusion, 56

The liver in myelo- and lymphoproliferative disease, 56Leukaemia, 57

Myeloid, 57Lymphoid, 57Hairy cell leukaemia, 57

Bone marrow transplantation, 57Lymphoma, 58

Jaundice in lymphoma, 59Primary hepatic lymphoma, 60Lymphosarcoma, 60Multiple myeloma, 61Angio-immunoblastic lymphadenopathy, 61Extra-medullary haemopoiesis, 61Systemic mastocytosis, 61Langerhans’ cell histiocytosis (histiocytosis X), 61

Lipid storage diseases, 62Primary and secondary xanthomatosis, 62Cholesteryl ester storage disease, 62Gaucher’s disease, 62Niemann–Pick disease, 63Sea-blue histiocyte syndrome, 64

5 Ultrasound, Computed Tomography and MagneticResonance Imaging, 67

Radio-isotope scanning, 67Positron emission tomography (PET), 67

Ultrasound, 67Doppler ultrasound, 69Endoscopic ultrasound, 70

Computed tomography, 70Magnetic resonance imaging, 74

MR spectroscopy, 76Conclusions and choice, 77

6 Hepato-cellular Failure, 81

General failure of health, 81Jaundice, 81

Vasodilatation and hyperdynamic circulation, 81Hepato-pulmonary syndrome, 82Pulmonary hypertension, 84

Fever and septicaemia, 86Fetor hepaticus, 87Changes in nitrogen metabolism, 87Skin changes, 87

Vascular spiders, 87Palmar erythema (liver palms), 88White nails, 89Mechanism of skin changes, 89

Endocrine changes, 89Hypogonadism, 90Hypothalamic–pituitary function, 91Metabolism of hormones, 91

General treatment, 92Precipitating factors, 92General measures, 92

7 Hepatic Encephalopathy, 93

Clinical features, 93Investigations, 95Neuropathological changes, 96

Clinical variants in cirrhotics, 97Differential diagnosis, 98Prognosis, 99

Pathogenetic mechanisms, 99Portal-systemic encephalopathy, 99Intestinal bacteria, 100Neurotransmission, 100Conclusions, 103

Treatment of hepatic encephalopathy, 104Diet, 104Antibiotics, 105Lactulose and lactilol, 105Sodium benzoate and l-ornithine-l-aspartate, 106Levodopa and bromocriptine, 106Flumazenil, 106Branched-chain amino acids, 106Other precipitating factors, 106Shunt occlusion, 106Temporary hepatic support, 107Hepatic transplantation, 107

8 Acute Liver Failure, 111

Definition, 111Causes, 111Clinical features, 113Investigations, 113Associations, 115Prognosis, 118Treatment, 119Conclusion, 124

9 Ascites, 127

Mechanism of ascites formation, 127Underfill and peripheral vasodilation hypotheses, 127Overfill hypothesis, 129Other renal factors, 129

vi Contents

Page 9: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

Circulation of ascites, 130Summary, 130

Clinical features, 130Spontaneous bacterial peritonitis, 132Treatment of cirrhotic ascites, 134

Refractory ascites, 138Prognosis, 139

Hepato-renal syndrome, 140Hyponatraemia, 143

10 The Portal Venous System and PortalHypertension, 147

Collateral circulation, 147Intra-hepatic obstruction (cirrhosis), 147Extra-hepatic obstruction, 148Effects, 148Pathology of portal hypertension, 148Varices, 149Portal hypertensive intestinal vasculopathy, 151

Haemodynamics of portal hypertension, 151Clinical features of portal hypertension, 152

History and general examination, 152Abdominal wall veins, 153Spleen, 154Liver, 154Ascites, 154Rectum, 154X-ray of the abdomen and chest, 154Barium studies, 155Endoscopy, 155

Imaging the portal venous system, 157Ultrasound, 157Doppler ultrasound, 157CT scan, 158Magnetic resonance angiography, 158Venography, 158Venographic appearances, 158Visceral angiography, 159Digital subtraction angiography, 159Splenic venography, 159Carbon dioxide wedged venography, 160Portal pressure measurement, 160Variceal pressure, 160Estimation of hepatic blood flow, 161Azygous blood flow, 162Experimental portal venous occlusion and

hypertension, 163Classification of portal hypertension, 163Extra-hepatic portal venous obstruction, 163

Aetiology, 163Clinical features, 165Prognosis, 166Treatment, 167Splenic vein obstruction, 167

Hepatic arterio-portal venous fistulae, 167Porto-hepatic venous shunts, 168

Intra-hepatic pre-sinusoidal and sinusoidal portalhypertension, 168

Portal tract lesions, 168Toxic causes, 168Hepato-portal sclerosis, 168Tropical splenomegaly syndrome, 169

Intra-hepatic portal hypertension, 169Cirrhosis, 169Non-cirrhotic nodules, 170

Bleeding oesophageal varices, 170Predicting rupture, 170Prevention of bleeding, 171Diagnosis of bleeding, 172Prognosis, 172

Management of acute variceal bleeding, 173Vaso-active drugs, 174Sengstaken-Blakemore tube, 174Endoscopic sclerotherapy and banding, 175Emergency surgery, 176Prevention of re-bleeding, 176

Portal-systemic shunt procedures, 177Porta-caval, 177Meso-caval, 178Selective ‘distal’ spleno-renal, 178General results of portal-systemic shunts, 178TIPS (transjugular intrahepatic portosystemic

shunt), 178Shunt stenosis and occlusion, 179Control of bleeding, 180TIPS encephalopathy, 180Circulatory changes, 180Other indications, 180Conclusions, 180

Hepatic transplantation, 180Pharmacological control of the portal circulation, 180Conclusions, 180

11 The Hepatic Artery and HepaticVeins: the Liver in CirculatoryFailure, 187

The hepatic artery, 187Hepatic artery occlusion, 188Hepatic arterial lesions following liver

transplantation, 189Aneurysms of the hepatic artery, 189Hepatic arteriovenous shunts, 190

The hepatic veins, 190Experimental hepatic venous obstruction, 191

Budd–Chiari (hepatic venous obstruction) syndrome,192

Pathological changes, 193Clinical features, 193

Contents vii

Page 10: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

Diagnosis, 195Prognosis, 196Treatment, 197Veno-occlusive disease, 198Spread of disease by the hepatic veins, 198

Circulatory failure, 199Hepatic changes in acute heart failure and shock, 199Ischaemic hepatitis, 200Post-operative jaundice, 200Jaundice after cardiac surgery, 201The liver in congestive heart failure, 201The liver in constrictive pericarditis, 203

12 Jaundice, 205

Bilirubin metabolism, 205Hepatic transport and conjugation of bilirubin, 205Distribution of jaundice in the tissues, 207Factors determining the depth of jaundice, 207

Classification of jaundice, 208Diagnosis of jaundice, 209

Clinical history, 209Examination, 211Diagnostic routine, 212

Familial non-haemolytic hyperbilirubinaemias, 213Primary hyperbilirubinaemia, 213Gilbert’s syndrome, 213Crigler–Najjar syndrome, 215Dubin–Johnson syndrome, 216Rotor type, 217The group of familial non-haemolytic

hyperbilirubinaemias, 217

13 Cholestasis, 219

Anatomy of the biliary system, 219Secretion of bile, 220

Cellular mechanisms, 221Syndrome of cholestasis, 223

Definition, 223Classification, 223Pathogenesis, 224Pathology, 224Clinical features, 226Diagnostic approach, 231Diagnostic possibilities, 232

14 Primary Biliary Cirrhosis, 241

Aetiology, 241Epidemiology and genetics, 243Clinical features, 243Diagnosis, 246Prognosis, 247

Treatment, 248Immune cholangiopathy, 250

Autoimmune cholangitis, 253

15 Sclerosing Cholangitis, 255

Primary sclerosing cholangitis (PSC), 255Infective sclerosing cholangitis, 261

Bacterial cholangitis, 261Immunodeficiency-related opportunistic

cholangitis, 261Graft-versus-host disease, 263

Vascular cholangitis, 263Drug-related cholangitis, 263Histiocytosis X, 263

16 Viral Hepatitis: General Features,Hepatitis A, Hepatitis E and OtherViruses, 267

Pathology, 267Clinical types, 268Investigations, 271Differential diagnosis, 271Prognosis, 272Treatment, 272Follow-up, 272

Hepatitis A virus, 273Epidemiology, 274Clinical course, 275Prognosis, 275Prevention, 275

Hepatitis E virus, 276Clinical features, 277Diagnostic tests, 277Liver biopsy, 277Prevention, 277

Hepatitis G virus, 278Hepatitis TT virus, 278Yellow fever, 279

Pathology, 279Clinical features, 279Treatment, 279

Infectious mononucleosis (Epstein–Barr virus), 279Hepatic histology, 279Clinical features, 280Diagnosis, 280Distinction from viral hepatitis, 280

Other viruses, 281Cytomegalovirus, 281Herpes simplex, 281Miscellaneous, 281

Hepatitis due to exotic viruses, 282Treatment, 283

viii Contents

Page 11: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

17 Hepatitis B Virus and Hepatitis DeltaVirus, 285

Hepatitis B virus (HBV), 285Acute hepatitis B, 287Epidemiology, 290Clinical course, 290Prevention, 292

Chronic hepatitis B, 294Clinical relapse and reactivation, 294Laboratory tests, 295Needle liver biopsy, 295Course and prognosis, 295Treatment, 296Outstanding problems, 298Screening for hepato-cellular carcinoma, 298

Hepatitis delta virus (HDV), 300Epidemiology, 300Diagnosis, 301Clinical features, 301Hepatic histology, 302Prevention, 302Treatment, 302

18 Hepatitis C Virus, 305

Molecular virology, 305Serological tests, 306Immune response, 307Epidemiology, 307Natural history, 308Clinical course, 308Hepatic histology, 309Hepatitis C and serum autoantibodies, 310Associated diseases, 310Diagnosis, 311Prognosis, 311Prevention: vaccines, 312Treatment, 312Hepatic transplantation, 316

19 Chronic Hepatitis: General Features, and Autoimmune ChronicDisease, 321

Clinical presentation, 321Hepatic histology, 322The role of liver biopsy, 322Classification, 324

Autoimmune chronic hepatitis, 325Type 1 (formerly called lupoid), 326Type 2, 326Primary biliary cirrhosis and immune cholangitis, 326

Chronic autoimmune hepatitis (type 1), 326

Aetiology, 326Hepatic pathology, 328Clinical features, 328Differential diagnosis, 330Treatment, 331Course and prognosis, 332Syncytial giant-cell hepatitis, 332

20 Drugs and the Liver, 335

Hepato-cellular zone 3 necrosis, 340Carbon tetrachloride, 342Amanita mushrooms, 343Paracetamol (acetaminophen), 343Salicylates, 344Hyperthermia, 344Hypothermia, 344Burns, 344

Hepato-cellular zone 1 necrosis, 344Ferrous sulphate, 345Phosphorus, 345

Mitochondrial cytopathies, 345Sodium valproate, 345Tetracyclines, 345Tacrine, 345Antiviral nucleoside analogues, 345Bacillus cereus, 346

Steato-hepatitis, 346Perhexiline maleate, 346Amiodarone, 346Synthetic oestrogens, 346Calcium channel blockers, 347

Fibrosis, 347Methotrexate, 347Other cytotoxic drugs, 347Arsenic, 348Vinyl chloride, 348Vitamin A, 348Retinoids, 348

Vascular changes, 348Sinusoidal dilatation, 348Peliosis hepatis, 349Veno-occlusive disease (VOD), 349

Acute hepatitis, 349Isoniazid, 350Methyl dopa, 351Halothane, 351Hydrofluorocarbons, 352Systemic antifungals, 352Oncology drugs, 352Nervous system modifiers, 353Sustained-release nicotinic acid (niacin), 353Sulphonamides and derivatives, 353Non-steroidal anti-inflammatory drugs, 353

Contents ix

Page 12: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

Anti-thyroid drugs, 353Quinidine and quinine, 353Troglitazone, 354Anti-convulsants, 354

Chronic hepatitis, 354Herbal remedies, 354Recreational drugs, 355

Canalicular cholestasis, 355Cyclosporin A, 355Ciprofloxacin, 355

Hepato-canalicular cholestasis, 355Chlorpromazine, 356Penicillins, 357Sulphonomides, 357Erythromycin, 357Haloperidol, 357Cimetidine and ranitidine, 357Oral hypoglycaemics, 357Tamoxifen, 357Other causes, 357Dextropropoxyphene, 357

Ductular cholestasis, 357Biliary sludge, 357Sclerosing cholangitis, 357Hepatic nodules and tumours, 358

Hepato-cellular carcinoma, 358Conclusions, 359

21 Hepatic Cirrhosis, 365

Classification of cirrhosis, 368Clinical cirrhosis, 371Compensated cirrhosis, 374Decompenstated cirrhosis, 375Prognosis, 376Treatment, 377

22 Alcohol and the Liver, 381

Risk factors for alcoholic liver diseases, 381Metabolism of alcohol, 382Mechanisms of liver injury, 384Morphological changes, 386

Fatty liver (steatosis), 386Alcoholic hepatitis, 387Cirrhosis, 387Early recognition, 389Investigation, 389

Clinical syndromes, 390Fatty liver, 390Acute alcoholic hepatitis, 390Hepatic cirrhosis, 391Cholestatic syndromes, 391Relationship to hepatitis B and C, 391Hepato-cellular cancer, 393

Associated features, 393Prognosis, 393Treatment, 394

Acute alcoholic hepatitis, 394Cirrhosis, 395Hepatic transplantation, 395

23 Iron Overload States, 399

Normal iron metabolism, 399Iron overload and liver damage, 401Genetic haemochromatosis, 401Other iron storage diseases, 407

Non-HFE-related inherited iron overload, 407Dysmetabolic syndrome, 408Erythropoietic siderosis, 408Late stage cirrhosis, 408Chronic viral hepatitis, 408Non-alcoholic fatty liver disease, 408Neonatal haemochromatosis, 409African iron overload (Bantu siderosis), 409Porphyria cutanea tarda, 409Haemodialysis, 409Acaeruloplasminaemia, 409Transferrin deficiency, 409

24 Wilson’s Disease, 413

Molecular genetics: pathogenesis, 413Pathology, 414Clinical picture, 415Hepatic forms, 416Neuropsychiatric forms, 417Renal changes, 417Other changes, 417Laboratory tests, 417Liver biopsy, 418Scanning, 418Diagnostic difficulties, 418Treatment, 419

Prognosis, 420Indian childhood cirrhosis, 421Hereditary acaeruloplasminaemia, 421

25 Nutritional and Metabolic LiverDiseases, 423

Malnutrition, 423Fatty liver, 423

Diagnosis, 424Classification, 424

Non-alcoholic fatty liver disease, 427Non-alcoholic hepatic steatosis, 428Non-alcoholic steatonecrosis, 428Effects of jejuno-ileal bypass, 429

x Contents

Page 13: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

Parenteral nutrition, 429Vitamins, 429Carbohydrate metabolism in liver disease, 431

Hypoglycaemia, 431Hyperglycaemia, 431

The liver in diabetes mellitus, 431Insulin and the liver, 431Hepatic histology, 431Clinical features, 432Liver function tests, 432

Hepato-biliary disease and diabetes, 432Glucose intolerance of cirrhosis, 432Treatment of diabetes in cirrhotic patients, 433

Glycogen storage diseases, 434Type I (von Gierke’s disease), 435Type II (Pompe’s disease), 436Type III (Cori’s disease), 436Type IV (Andersen’s disease), 437Type VI (Hers’ disease), 437Hepatic glycogen synthetase deficiency (type 0), 437

Hereditary fructose intolerance, 438Glutaric aciduria type II, 438Galactosaemia, 438Mucopolysaccharidoses, 439Familial hypercholesterolaemia, 439Amyloidosis, 440a1-Antitrypsin deficiency, 443Hereditary tyrosinaemia, 445Cystic fibrosis, 446Liver and thyroid, 447

Thyrotoxicosis, 447Myxoedema, 447Changes with hepato-cellular disease, 447

Liver and adrenal, 448Liver and growth homone, 448Hepatic porphyrias, 448

Acute intermittent porphyria, 449Hereditary coproporphyria, 450Variegate porphyria, 450Porphyria cutanea tarda, 450Erythropoietic protoporphyria, 450Congenital erythropoietic porphyria, 451Hepato-erythropoietic porphyria, 451Secondary coproporphyrias, 451

Hereditary haemorrhagic telangiectasia, 452Dystrophia myotonica, 452

26 The Liver in Infancy and Childhood, 453

Neonatal hyperbilirubinaemia, 453Unconjugated hyperbilirubinaemia, 453Haemolytic disease of the newborn, 454

Hepatitis and cholestatic syndromes (conjugatedhyperbilirubinaemia), 455

Viral hepatitis, 457Non-viral causes of hepatitis, 459Urinary tract infections, 459Neonatal hepatitis syndrome, 459

Infantile cholangiopathies, 460Biliary atresia, 460Extra-hepatic biliary atresia, 460Alagille’s syndrome (arterio-hepatic dysplasia), 462Prolonged parenteral nutrition, 462Abnormal bile acid synthesis, 463Genetic cholestatic syndromes, 463Symptomatic treatment of cholestatic

syndromes, 464Other causes of cholestatic jaundice, 464Reye’s syndrome, 465

Reye-like syndromes, 465Cirrhosis in infancy and childhood, 465

Indian childhood cirrhosis, 466Non-Indian childhood cirrhosis (copper-associated

liver disease), 466Hepatic steatosis, 467

Fetal alcohol syndrome, 467Idiopathic steato-hepatitis, 467

Tumour of the liver, 467Hamartomas, 467Mesenchymal hamartoma, 467Malignant mesenchymoma (undifferentiated

sarcoma), 467Adenomas, 467Hepato-cellular carcinoma, 467Hepatoblastoma, 467Infantile haemangio-endothelioma, 467Nodular regenerative hyperplasia, 468Hepatic transplantation, 468

27 The Liver in Pregnancy, 471

Normal pregnancy, 471Liver disease in pregnancy, 471

Hyperemesis gravidarum, 471Liver diseases of late pregnancy, 471

Acute fatty liver of pregnancy, 471Pregnancy toxaemias, 474The HELLP syndrome, 474Toxaemia and the HELLP syndrome, 475Hepatic haemorrhage, 475Cholestasis of pregnancy, 475Budd–Chiari syndrome, 476

Intercurrent jaundice, 476Viral hepatitis, 476Biliary tract disease, 477

Hepato-toxic drugs and the pregnant woman, 478Effect of pregnancy on pre-existing chronic liver

disease, 478Pregnancy in liver transplant recipients, 478

Contents xi

Page 14: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

28 The Liver in Systemic Disease,Granulomas and Hepatic Trauma, 481

The liver in collagen diseases, 481Arthropathy associated with liver disease, 481

Genetic haemochromatosis, 481Hepatitis B virus (HBV) associations, 481Hepatitis C virus (HCV) associations, 482

Hepatic granulomas, 482Clinical syndrome of hepatic granulomas, 483‘Granulomatous hepatitis’, 484Sarcoidosis, 484Granulomatous drug reactions, 486Granulomas associated with infections, 487Hepatic granulomas in the patient with AIDS, 488Industrial causes, 489Other conditions with hepatic granulomas, 489

Hepato-biliary associations of inflammatory boweldisease, 490

Hepatic trauma, 490Rupture of the gallbladder, 492

29 The Liver in Infections, 495

Pyogenic liver abscess, 495Other infections, 498Hepatic amoebiasis, 498Tuberculosis of the liver, 501Hepatic actinomycosis, 502Other fungal infections, 502Syphilis of the liver, 503

Congenital, 503Secondary, 503Tertiary, 503Jaundice complicating penicillin treatment, 504

Leptospirosis, 504Weil’s disease, 504Other types of leptospirosis, 506

Relapsing fever, 507Lyme disease, 507Q fever, 507

Rocky mountain spotted fever, 508Schistosomiasis (bilharziasis), 508Malaria, 510Kala-azar (leishmaniasis), 511Hydatid disease, 511

Echinococcus multilocularis (alveolarechinococcosis), 516

Ascariasis, 517Strongyloides stercoralis, 518Trichiniasis, 518Toxocara canis (visceral larva migrans), 518Liver flukes, 518

Clonorchis sinensis, 518

Fasciola hepatica, 519Recurrent pyogenic cholangitis, 519

Peri-hepatitis, 520Hepato-biliary disease in HIV infection, 520

Infections, 521Hepatitis B, C and D co-infection, 522Neoplasms, 522Hepato-biliary disease, 523Acaculous cholecystitis, 524

Jaundice of infections, 525Bacterial pneumonia, 525Septicaemia and septic shock, 525

30 Nodules and Benign Liver Lesions, 527

Small hepato-cellular cancer, 527Nodules in the absence of underlying liver disease, 528Simple cysts, 528Haemangioma, 528Focal nodular hyperplasia, 530Hepatic adenoma, 531Focal nodular hyperplasia and adenoma contrasted, 532Liver metastases, 532Other benign tumours, 534

Cholangioma (bile duct adenoma), 534Biliary cystadenoma, 534

Nodular regenerative hyperplasia, 534Partial nodular transformation, 535

31 Malignant Liver Tumours, 537

Hepato-cellular cancer, 537Aetiological factors, 537Pathology, 540Clinical features, 541Tumour localization, 543Needle liver biopsy, 546Screening, 546Prognosis and risk factors, 547Surgical treatment, 547Non-surgical treatment, 548

Fibro-lamellar carcinoma of the liver, 551Hepatoblastoma, 551Intra-hepatic cholangiocarcinoma, 552Combined hepato-cellular–cholangiocarcinoma, 553Other primary liver tumours, 553

Cystadenocarcinoma, 553Angiosarcoma (haemangio-endothelioma), 553Epitheloid haemangio-endothelioma, 554Undifferentiated sarcoma of the liver, 554

Benign tumours of the liver, 554Mesenchymal hamartoma, 554

Paraneoplastic hepatopathy, 554Hepatic metastases, 554

xii Contents

Page 15: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

32 Imaging of the Biliary Tract:Interventional Radiology andEndoscopy, 563

Plain film of the abdomen, 563Ultrasound (US), 563

Bile ducts, 563Gallbladder, 563

Computed tomography (CT), 564Magnetic resonance cholangiopancreatography

(MRCP), 565Endoscopic ultrasound (EUS), 566Biliary scintigraphy, 567Oral cholecystography, 567Intravenous cholangiography, 568Endoscopic retrograde cholangiopancreatography, 568Endoscopic sphincterotomy, 570Endoscopic biliary endoprostheses, 573Percutaneous trans-hepatic cholangiography, 576

Percutaneous bile drainage, 576Percutaneous biliary endoprosthesis, 577Resectability of tumours, 578Choice between surgical and non-surgical palliation of

malignant obstruction, 578Choice between endoscopic and percutaneous

approach, 578Percutaneous cholecystostomy, 578Operative and post-operative cholangiography, 579

33 Cysts and Congenital BiliaryAbnormalities, 583

Fibropolycystic disease, 583Childhood fibropolycystic diseases, 584

Adult polycystic disease, 584Congenital hepatic fibrosis, 586

Congenital intra-hepatic biliary dilatation (Caroli’sdisease), 588

Congenital hepatic fibrosis and Caroli’s disease, 589Choledochal cyst, 589Microhamartoma (von Meyenberg complexes), 591Carcinoma secondary to fibropolycystic

disease, 591Solitary non-parasitic liver cyst, 591Other cysts, 591

Congenital anomalies of the biliary tract, 592Absence of the gallbladder, 592Double gallbladder, 592Accessory bile ducts, 593Left-sided gallbladder, 594Rokitansky–Aschoff sinuses, 594Folded gallbladder, 594Diverticula of the gallbladder and ducts, 594Intra-hepatic gallbladder, 594Congenital adhesions to the gallbladder, 594

Floating gallbladder and torsion of the gallbladder, 594

Anomalies of the cystic duct and cystic artery, 595

34 Gallstones and InflammatoryGallbladder Diseases, 597

Composition of gallstones, 597Composition of bile, 597

Factors in cholesterol gallstone formation, 598Pigment gallstones, 603Radiology of gallstones, 603Natural history of gallstones, 604

Silent gallstones, 605Treatment of gallstones in the gallbladder, 605

Cholecystectomy, 605Laparoscopic cholecystectomy, 605

Non-surgical treatment of gallstones in the gallbladder, 607

Dissolution therapy, 607Direct solvent dissolution, 608Shock-wave therapy, 608

Percutaneous cholecystolithotomy, 609Conclusions, 609

Acute cholecystitis, 610Empyema of the gallbladder, 612Perforation of the gallbladder, 612Emphysematous cholecystitis, 612Chronic calculous cholecystitis, 613Acalculous cholecystitis, 614

Acute, 614Chronic, 614Typhoid cholecystitis, 614Acute cholecystitis in AIDS, 614Other associations, 615

Other gallbladder pathology, 615Cholesterolosis of the gallbladder, 615Xanthogranulomatous cholecystitis, 615Adenomyomatosis, 615Porcelain gallbladder, 615

Post-cholecystectomy problems, 615Sphincter of Oddi dysfunction, 616Gallstones in the common bile duct

(choledocholithiasis), 616Managment of common duct stones, 618

Acute obstructive suppurative cholangitis, 618Acute cholangitis, 618

Common duct stones without cholangitis, 619Patients with gallbladder in situ, 619Acute gallstone pancreatitis, 619Large common duct stones, 619Trans T-tube tract removal of stones, 620Intra-hepatic gallstones, 620Mirizzi’s syndrome, 620

Biliary fistulae, 621

Contents xiii

Page 16: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

External, 621Internal, 621

Gallstone ileus, 621Haemobilia, 622Bile peritonitis, 622Association of gallstones with other diseases, 623

Colorectal and other cancers, 623Diabetes mellitus, 623

35 Benign Stricture of the Bile Ducts, 629

Post-cholecystectomy, 629Bile duct/bowel anastomotic stricture, 634Post liver transplantation, 635Primary sclerosing cholangitis, 636Other causes, 636Summary, 636

36 Diseases of the Ampulla of Vater andPancreas, 639

Peri-ampullary carcinoma, 639Benign villous adenoma of the ampulla of Vater, 644Cystic tumours of the pancreas, 644Endocrine tumours of the pancreas, 644

Chronic pancreatitis, 644Obstruction of the common bile duct by enlarged lymph

glands, 645Other causes of extrinsic pressure on the common bile

duct, 645

37 Tumours of the Gallbladder and BileDucts, 647

Benign lesions of the gallbladder, 647Carcinoma of the gallbladder, 647

Other tumours, 648Benign tumours of the extra-hepatic bile duct, 648Carcinoma of the bile duct (cholangiocarcinoma), 648Cholangiocellular carcinoma, 654Metastases at the hilum, 655

38 Hepatic Transplantation, 657

Selection of patients, 657Candidates: outcome, 657

Cirrhosis, 659Autoimmune chronic hepatitis, 659Chronic viral hepatitis, 659Neonatal hepatitis, 660Alcoholic liver disease, 660Cholestatic liver disease, 660Primary metabolic disease, 661Acute liver failure, 662Malignant disease, 662Miscellaneous, 663

Absolute and relative contraindications, 663Absolute, 663Relative (higher risk), 664

General preparation of the patient, 664Donor selection and operation, 664The recipient operation, 665

Segmental (split liver) transplantation, 665Auxiliary liver transplantation, 666Xeno-transplantation, 666Domino liver transplantation, 666Hepatocyte transplantation, 667Liver transplantation in paediatrics, 667

Immunosuppression, 667Tolerance, 668

Post-operative course, 668Post-transplantation complications, 668

Rejection, 671Infections, 673Malignancies, 675Drug-related toxicity, 675Disease recurrence, 675Central nervous system toxicity, 675Bone disease, 675Ectopic soft-tissue calcification, 675

Conclusion, 675

Index, 681

xiv Contents

Page 17: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

The eleventh edition welcomes the new Millenium.Progress in basic and clinical hepatology remains ex-ponential. Since 1997, the advances have been wide-ranging, with those in molecular and cellular biology,and in diagnosis and treatment, leading the way. In aworld in which information technology gives all tooready access to individual publications, the eleventhedition sets the new within established knowledge andpractice.

Viral hepatitis remains the worldwide hepatologicalchallenge. This is reflected in a change in format withseparate chapters on hepatitis B and C. Molecular virol-ogy continues to expose the inner workings of all theviruses. New therapeutic approaches are proving moreeffective against hepatitis C. Molecular and cellular biol-ogists are showing us the importance of apoptosis andthe intricate regulation of fibrosis. Mutation analysis fordiagnosis of genetic haemochromatosis is routine, whilethe identification of the haemochromatosis gene has ledto a surge of exploration in iron metabolism. Canaliculartransporters have been cloned and linked to cholestaticsyndromes, giving a new perspective to the bile plugseen under the microscope. Advances in imaging, par-ticularly magnetic resonance, continue to reduce theneed for invasive techniques. Patients needing trans-plantation benefit from improvements in immuno-suppression and surgical techniques, while there issteady progress in the management of complications ofcirrhosis.

This edition contains more than 1000 new referencesand 100 new figures. Developments in publishing allowa more colourful format, but care has been taken to preserve clarity. Experience has shown that students,interns, postgraduate trainees as well as generalists andspecialist clinicians have found previous editions useful.The goal of the book remains unchanged: a textbook ofmanageable size, critical and current.

We are indebted to many colleagues for their generouscontributions to this edition including in particular Professor Peter Scheuer, Professor Amar Dhillon and Dr

Susan Davies for histological material, and Dr RobertDick, Dr Tony Watkinson and Dr Jon Tibballs for radio-logical images. We would also like to express our greatthanks to Dr Leslie Berger, Dr Andrew Burroughs, DrJohn Buscombe, Dr Martyn Caplin, Professor GeoffreyDusheiko, Dr David Harry, Dr Andrew Hilson, ProfessorHumphrey Hodgson, Professor Neil McIntyre, Dr KevinMoore, Dr Marsha Morgan, Dr Chris Kibbler and DrDavid Patch for their help in the preparation of thisedition.

Miss Aileen Duggan and Miss Karma Raines haveassisted tirelessly with their meticulous secretarialsupport. The clarity and style of figures preserved fromprevious editions owes much to the artistry of MissJanice Cox over many years.

We are grateful to Blackwell Publishing and, in par-ticular, Rebecca Huxley for her tireless help with bothmanuscript and proofs, and for responding without amurmur to demands within a tight schedule. We alsothank Jane Fallows who has reformatted and colouredall the previous line drawings as well as creating themany new and visually inviting figures for the eleventhedition.

The preface to the first edition which was published in 1955 refers to daughters Amanda and Auriole.Amanda is now an ordained Minister in the BaptistChurch, and Auriole is working with Kent Police.Grandchildren have arrived, including Alice aged 9 andEmily aged 6.

On the 13th July 2001, the senior author was elected aFellow of the Royal Society in its 341st year, a Societyfounded to improve natural knowledge. This honourwas achieved because of the support of all the cliniciansand scientists who have contributed to the Liver Unitand its associated departments at The Royal Free. Thenew Millenium is indeed an exciting time for all thoseworking to solve the puzzles within hepato-biliarydisease.

sheila sherlockjames dooley

November 2001

Preface to the Eleventh Edition

xv

Page 18: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

My aim in writing this book has been to present a com-prehensive and up-to-date account of diseases of theliver and biliary system, which I hope will be of value tophysicians, surgeons and pathologists and also a refer-ence book for the clinical student. The modern literaturehas been reviewed with special reference to articles ofgeneral interest. Many older more specialized classicalcontributions have therefore inevitably been excluded.

Disorders of the liver and biliary system may be classi-fied under the traditional concept of individual diseases.Alternatively, as I have endeavoured in this book, theymay be described by the functional and morphologicalchanges which they produce. In the clinical managementof a patient with liver disease, it is important to assess thedegree of disturbance of four functional and morpho-logical components of the liver—hepatic cells, vascularsystem (portal vein, hepatic artery and hepatic veins),bile ducts and reticulo-endothelial system. The typicalreaction pattern is thus sought and recognized beforeattempting to diagnose the causative insult. Clinical andlaboratory methods of assessing each of these com-ponents are therefore considered early in the book.Descriptions of individual diseases follow as illustrativeexamples. It will be seen that the features of hepatocellu-lar failure and portal hypertension are described ingeneral terms as a foundation for subsequent discussionof virus hepatitis, nutrition liver disease and the cir-rhoses. Similarly blood diseases and infections of theliver are included with the reticulo-endothelial system,and disorders of the biliary tract follow descriptions ofacute and chronic bile duct obstruction.

I would like to acknowledge my indebtedness to myteachers, the late Professor J. Henry Dible, the late Pro-fessor Sir James Learmonth and Professor Sir JohnMcMichael, who stimulated my interest in hepaticdisease, and to my colleagues at the PostgraduateMedical School and elsewhere who have generouslyinvited me to see patients under their care. I am gratefulto Dr A. G. Bearn for criticizing part of the typescript and to Dr A. Paton for his criticisms and careful proof

reading. Miss D. F. Atkins gave much assistance withproof reading and with the bibliography. Mr PerSaugman and Mrs J. M. Green of Blackwell ScientificPublications have co-operated enthusiastically in theproduction of this book.

The photomicrographs were taken by Mr E. V. Will-mott, frps, and Mr C. A. P. Graham from section pre-pared by Mr J. G. Griffin and the histology staff of thePostgraduate Medical School. Clinical photographs arethe work of Mr C. R. Brecknell and his assistants. Theblack and white drawings were made by Mrs H. M. G.Wilson and Mr D. Simmonds. I am indebted to them allfor their patience and skill.

The text includes part of unpublished materialincluded in a thesis submitted in 1944 to the Universityof Edinburgh for the degree of MD, and part of an essayawarded the Buckston–Browne prize of the HarveianSociety of London in 1953. Colleagues have allowed meto include published work of which they are jointlyresponsible. Dr Patricia P. Franklyn and Dr R. E. Steinerhave kindly loaned me radiographs. Many authors havegiven me permission to reproduce illustrations anddetailed acknowledgments are given in the text. I wishalso to thank the editors of the following journals for permission to include illustrations: American Journal ofMedicine, Archives of Pathology, British Heart Journal, Circulation, Clinical Science, Edinburgh Medical Journal,Journal of Clinical Investigation, Journal of Laboratory andClinical Investigation, Journal of Pathology and Bacteriology,Lancet, Postgraduate Medical Journal, Proceedings of theStaff Meetings of the Mayo Clinic, Quarterly Journal of Medi-cine, Thorax and also the following publishers: Butter-worth’s Medical Publications, J. & A. Churchill Ltd, TheJosiah Macy Junior Foundation and G. D. Searle & Co.

Finally I must thank my husband, Dr D. GeraintJames, who, at considerable personal inconvenience,encouraged me to undertake the writing of this book andalso criticized and rewrote most of it. He will not allowme to dedicate it to him.

sheila sherlock

Preface to the First Edition

xvi

Page 19: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

The liver, the largest organ in the body, weighs1200–1500g and comprises one-fiftieth of the total adultbody weight. It is relatively larger in infancy, comprisingone-eighteenth of the birth weight. This is mainly due toa large left lobe.

Sheltered by the ribs in the right upper quadrant, theupper border lies approximately at the level of thenipples. There are two anatomical lobes, the right beingabout six times the size of the left (figs 1.1–1.3). Lessersegments of the right lobe are the caudate lobe on the posterior surface and the quadrate lobe on the inferiorsurface. The right and left lobes are separated anteriorlyby a fold of peritoneum called the falciform ligament,

posteriorly by the fissure for the ligamentum veno-sum and inferiorly by the fissure for the ligamentumteres.

The liver has a double blood supply. The portal veinbrings venous blood from the intestines and spleen andthe hepatic artery, coming from the coeliac axis, suppliesthe liver with arterial blood. These vessels enter the liverthrough a fissure, the porta hepatis, which lies far back onthe inferior surface of the right lobe. Inside the porta, theportal vein and hepatic artery divide into branches to theright and left lobes, and the right and left hepatic bileducts join to form the common hepatic duct. The hepaticnerve plexus contains fibres from the sympathetic ganglia

1

Chapter 1Anatomy and Function

Right lobe Diaphragm

Left lobe

Falciform ligament

Ligamentum teres

Gallbladder

Fig. 1.1. Anterior view of the liver.

Caudatelobe

Leftlobe

Fissure forligamentumvenosum

Inferiorvena cava

Gallbladder

Rightlobe

Bare area

Fig. 1.2. Posterior view of the liver.

Gastric impressionPortal veinPorta hepatis

Hepatic artery

Bile duct

Ligamentum teres

Quadrate lobe

Renal impression

Duodenalimpression

Colonic impression

Gallbladder

Fissure forligamentum venosum

Fig. 1.3. Inferior view of the liver.

Page 20: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

branches and each of these supplies two further subunits(variously called sectors). The sectors on the right sideare anterior and posterior and, in the left lobe, medialand lateral — giving a total of four sectors (fig. 1.4). Usingthis definition, the right and left side of the liver aredivided not along the line of the falciform ligament, butalong a slightly oblique line to the right of this, drawnfrom the inferior vena cava above to the gallbladder bed below. The right and left side are independent with regard to portal and arterial blood supply, and biledrainage. Three plains separate the four sectors andcontain the three major hepatic vein branches.

Closer analysis of these four hepatic sectors producesa further subdivision into segments (fig. 1.5). The rightanterior sector contains segments V and VIII; right poste-rior sector, VI and VII; left medial sector, IV; left lateralsector, segments II and III. There is no vascular anasto-mosis between the macroscopic vessels of the segmentsbut communications exist at sinusoidal level. Segment I,the equivalent of the caudate lobe, is separate from theother segments and does not derive blood directly fromthe major portal branches or drain by any of the threemajor hepatic veins.

This functional anatomical classification allows inter-pretation of radiological data and is of importance to the

2 Chapter 1

T7–T10, which synapse in the coeliac plexus, the rightand left vagi and the right phrenic nerve. It accompaniesthe hepatic artery and bile ducts into their finest ramifi-cations, even to the portal tracts and hepatic parenchyma[4].

The ligamentum venosum, a slender remnant of theductus venosus of the fetus, arises from the left branch ofthe portal vein and fuses with the inferior vena cava atthe entrance of the left hepatic vein. The ligamentum teres,a remnant of the umbilical vein of the fetus, runs in thefree edge of the falciform ligament from the umbilicus tothe inferior border of the liver and joins the left branch ofthe portal vein. Small veins accompanying it connect theportal vein with veins around the umbilicus. Thesebecome prominent when the portal venous system isobstructed inside the liver.

The venous drainage from the liver is into the right andleft hepatic veins which emerge from the back of the liverand at once enter the inferior vena cava very near itspoint of entry into the right atrium.

Lymphatic vessels terminate in small groups of glandsaround the porta hepatis. Efferent vessels drain intoglands around the coeliac axis. Some superficial hepaticlymphatics pass through the diaphragm in the falciformligament and finally reach the mediastinal glands.Another group accompanies the inferior vena cava intothe thorax and ends in a few small glands around theintrathoracic portion of the inferior vena cava.

The inferior vena cava makes a deep groove to the rightof the caudate lobe about 2cm from the mid-line.

The gallbladder lies in a fossa extending from the in-ferior border of the liver to the right end of the portahepatis.

The liver is completely covered with peritoneum,except in three places. It comes into direct contact withthe diaphragm through the bare area which lies to theright of the fossa for the inferior vena cava. The otherareas without peritoneal covering are the fossae for theinferior vena cava and gallbladder.

The liver is kept in position by peritoneal ligamentsand by the intra-abdominal pressure transmitted by thetone of the muscles of the abdominal wall.

Functional anatomy: sectors and segments

Based on the external appearances described above, theliver has a right and left lobe separated along the line ofinsertion of the falciform ligament. This separation,however, does not correlate with blood supply or biliarydrainage. A functional anatomy is now recognized basedupon studies of vascular and biliary casts made by inject-ing vinyl into the vessels and bile ducts. This classifica-tion correlates with that seen by imaging techniques.

The main portal vein divides into right and left

posterior

anterior

medial

Left side

Right side

Right Left

lateral

Fig. 1.4. The sectors of the human liver.

Page 21: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

surgeon planning a liver resection. There are wide varia-tions in portal and hepatic vessel anatomy which can bedemonstrated by spiral computed tomography (CT) andmagnetic resonance imaging (MRI) reconstruction [41].

Anatomy of the biliary tract (fig. 1.6)

The right and left hepatic ducts emerge from the liver andunite in the porta hepatis to form the common hepatic duct.This is soon joined by the cystic duct from the gallbladderto form the common bile duct.

The common bile duct runs between the layers of thelesser omentum, lying anterior to the portal vein and tothe right of the hepatic artery. Passing behind the first partof the duodenum in a groove on the back of the head of thepancreas, it enters the second part of the duodenum. Theduct runs obliquely through the postero-medial wall,usually joining the main pancreatic duct to form theampulla of Vater (1720). The ampulla makes the mucousmembrane bulge inwards to form an eminence: the duodenal papilla. In about 10–15% of subjects the bile andpancreatic ducts open separately into the duodenum.

The dimensions of the common bile duct depend onthe technique used. At operation it is about 0.5–1.5cm indiameter. Using ultrasound the values are less, thecommon bile duct being 2–7mm, with values greaterthan 7mm being regarded as abnormal. Using endo-scopic cholangiography, the duct diameter is usually lessthan 11mm, although after cholecystectomy it may bemore in the absence of obstruction.

The duodenal portion of the common bile duct is sur-rounded by a thickening of both longitudinal and circu-lar muscle fibres derived from the intestine. This is calledthe sphincter of Oddi (1887).

The gallbladder is a pear-shaped bag 9cm long with acapacity of about 50ml. It always lies above the trans-verse colon, and is usually next to the duodenal capoverlying, but well anterior to, the right renal shadow.

Any decrease in concentrating power is accompaniedby reduced distensibility. The fundus is the wider endand is directed anteriorly; this is the part palpated whenthe abdomen is examined. The body extends into a

Anatomy and Function 3

VIIVIII

V VI

IVI

II

III

Fig. 1.5. Schematic representation of thefunctional anatomy of the liver. Threemain hepatic veins (dark blue) divide theliver into four sectors, each of themreceiving a portal pedicle; hepatic veinsand portal veins are intertwined as thefingers of two hands [5].

Sphincter of Oddi

Commonhepaticduct

Commonbileduct

Hepaticducts

Pancreatic duct

Ampulla of VaterDuodenalpapilla

Hartmann'spouch

Neck

Cystic duct

Heister's spiral valve

Duodenum

Fig. 1.6. Gallbladder and biliary tract.

Page 22: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

narrow neck which continues into the cystic duct. Thevalves of Heister are spiral folds of mucous membrane inthe wall of the cystic duct and neck of the gallbladder.Hartmann’s pouch is a sacculation at the neck of the gall-bladder; this is a common site for a gallstone to lodge.

The wall consists of a musculo-elastic networkwithout definite layers, the muscle being particularlywell developed in the neck and fundus. The mucousmembrane is in delicate closely woven folds; instead ofglands there are deep indentations of mucosa, the cryptsof Luschka, which penetrate into the muscular layer.There is no submucosa or muscularis mucosae.

The Rokitansky–Aschoff sinuses are branching evagina-tions from the gallbladder lumen lined by mucosa reach-ing into the muscularis of the gallbladder. They play animportant part in acute cholecystitis and gangrene of thegallbladder wall.

Blood supply. The gallbladder receives blood from thecystic artery. This branch of the hepatic artery is large, tortuous and variable in its anatomical relationships.Smaller blood vessels enter from the liver through thegallbladder fossa. The venous drainage is into the cysticvein and thence into the portal venous system.

The arterial blood supply to the supra-duodenal bileduct is generally by two main (axial) vessels which run beside the bile duct. These are supplied predomi-nantly by the retro-duodenal artery from below, and theright hepatic artery from above, although many othervessels contribute. This pattern of arterial supply wouldexplain why vascular damage results in bile duct stricturing [24].

Lymphatics. There are many lymphatic vessels in thesubmucous and subperitoneal layers. These drainthrough the cystic gland at the neck of the gallbladder to glands along the common bile duct, where they anas-tomose with lymphatics from the head of the pancreas.

Nerve supply. The gallbladder and bile ducts are liber-ally supplied with nerves, from both the parasympa-thetic and the sympathetic system.

Development of the liver and bile ducts

The liver begins as a hollow endodermal bud from theforegut (duodenum) during the third week of gestation.The bud separates into two parts — hepatic and biliary.The hepatic part contains bipotential progenitor cells thatdifferentiate into hepatocytes or ductal cells, which formthe early primitive bile duct structures (ductal plates).Differentiation is accompanied by changes in cytoker-atin type within the cell [40]. Normally, this collection of rapidly proliferating cells penetrates adjacent meso-dermal tissue (the septum transversum) and is met byingrowing capillary plexuses from the vitelline andumbilical veins which will form the sinusoids. The con-nection between this proliferating mass of cells and the

foregut, the biliary part of the endodermal bud, will formthe gallbladder and extra-hepatic bile ducts. Bile beginsto flow at about the 12th week. Haemopoietic cells,Kupffer cells and connective tissue cells are derived fromthe mesoderm of the septum transversum. The fetal liver has a major haemopoietic function which subsidesduring the last 2 months of intra-uterine life so that onlya few haemopoietic cells remain at birth.

Anatomical abnormalities of the liver

These are being increasingly diagnosed with more wide-spread use of CT and ultrasound scanning.

Accessory lobes. The livers of the pig, dog and camel aredivided into distinct and separate lobes by strands ofconnective tissue. Occasionally, the human liver mayshow this reversion and up to 16 lobes have beenreported. This abnormality is rare and without clinicalsignificance. The lobes are small and usually on theunder surface of the liver so that they are not detectedclinically but are noted incidentally at scanning, opera-tion or necropsy. Rarely they are intrathoracic. An acces-sory lobe may have its own mesentery containinghepatic artery, portal vein, bile duct and hepatic vein.This may twist and demand surgical intervention.

Riedel’s lobe is fairly common and is a downwardtongue-like projection of the right lobe of the liver. It is asimple anatomical variation; it is not a true accessorylobe. The condition is more frequent in women. It isdetected as a mobile tumour on the right side of theabdomen which descends with the diaphragm on inspi-ration. It may come down as low as the right iliac region.It is easily mistaken for other tumours in this area, es-pecially a visceroptotic right kidney. It does not causesymptoms and treatment is not required. Scanning maybe used to identify Riedel’s lobe and other anatomicalabnormalities.

Cough furrows on the liver are parallel grooves on theconvexity of the right lobe. They are one to six in numberand run antero-posteriorly, being deeper posteriorly.They are said to be associated with a chronic cough.

Corset liver. This is a fibrotic furrow or pedicle on theanterior surface of both lobes of the liver just below thecostal margin. The mechanism is unknown, but it affectselderly women who have worn corsets for many years. Itpresents as an abdominal mass in front of and below theliver and is isodense with the liver. It may be confusedwith a hepatic tumour.

Lobar atrophy. Interference with the portal supply orbiliary drainage of a lobe may cause atrophy. There isusually hypertrophy of the opposite lobe. Left lobeatrophy found at post-mortem or during scanning is notuncommon and is probably related to reduced bloodsupply via the left branch of the portal vein. The lobe isdecreased in size with thickening of the capsule, fibrosis

4 Chapter 1

Page 23: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

and prominent biliary and vascular markings. The vas-cular problem may date from the time of birth.

Obstruction to the right or left hepatic bile duct bybenign stricture or cholangiocarcinoma is now the mostcommon cause of lobar atrophy [16]. The alkaline phos-phatase is usually elevated. The bile duct may not bedilated within the atrophied lobe. Relief of obstructionmay reverse the changes if cirrhosis has not developed.Distinction between a biliary and portal venous aetiol-ogy may be made using technetium-labelled iminodi-acetic acid (IDA) and colloid scintiscans. A small lobewith normal uptake of IDA and colloid is compatiblewith a portal aetiology. Reduced or absent uptake ofboth isotopes favours biliary disease.

Agenesis of the right lobe [27]. This rare lesion may be anincidental finding associated, probably coincidentally,with biliary tract disease and also with other congenitalabnormalities. It can cause pre-sinusoidal portal hyper-tension. The other liver segments undergo compen-satory hypertrophy. It must be distinguished from lobaratrophy due to cirrhosis or hilar cholangiocarcinoma.

Anatomical abnormalities of the gallbladder andbiliary tract are discussed in Chapter 33.

Surface marking (figs 1.7, 1.8)

Liver. The upper border of the right lobe is on a level withthe 5th rib at a point 2cm medial to the right mid-clavicu-lar line (1cm below the right nipple). The upper borderof the left lobe corresponds to the upper border of the 6thrib at a point in the left mid-clavicular line (2cm belowthe left nipple). Here only the diaphragm separates theliver from the apex of the heart.

The lower border passes obliquely upwards from the9th right to the 8th left costal cartilage. In the right nippleline it lies between a point just under to 2cm below thecostal margin. It crosses the mid-line about mid-waybetween the base of the xiphoid and the umbilicus andthe left lobe extends only 5cm to the left of the sternum.

Gallbladder. Usually the fundus lies at the outer borderof the right rectus abdominis muscle at its junction withthe right costal margin (9th costal cartilage) (fig. 1.8). Inan obese subject it may be difficult to identify the outerborder of the rectus sheath and the gallbladder may thenbe located by the Grey–Turner method. A line is drawnfrom the left anterior superior iliac spine through theumbilicus; its intersection with the right costal marginindicates the position of the gallbladder. These guide-lines depend upon the individual’s build. The fundusmay occasionally be found below the iliac crest.

Methods of examination

Liver. The lower edge should be determined by palpa-tion just lateral to the right rectus muscle. This avoidsmistaking the upper intersection of the rectus sheath forthe liver edge.

Anatomy and Function 5

Fig. 1.7. The surface marking of the liver.

Method I

Gallbladder

Outer borderright rectussheath

Method II

Costalmargin Gallbladder

Umbilicus

Anteriorsuperiorspine

Fig. 1.8. Surface markings of thegallbladder. Method I: the gallbladder isfound where the outer border of the rightrectus abdominis muscle intersects the9th costal cartilage. Method II: a linedrawn from the left anterior superioriliac spine through the umbilicusintersects the costal margin at the site ofthe gallbladder.

Page 24: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

The liver edge moves 1–3cm downwards with deepinspiration. It is usually palpable in normal subjectsinspiring deeply. The edge may be tender, regular orirregular, firm or soft, thickened or sharp. The loweredge may be displaced downwards by a low diaphragm,for instance in emphysema. Movements may be particu-larly great in athletes or singers. Some patients withpractice become very efficient at ‘pushing down’ theliver. The normal spleen can become palpable in similarfashion. Common causes of a liver palpable below the umbilicus are malignant deposits, polycystic orHodgkin’s disease, amyloidosis, congestive cardiacfailure and gross fatty change. Rapid change in liver sizemay occur when congestive cardiac failure is corrected,cholestatic jaundice relieved, or when severe diabetes iscontrolled. The surface can be palpated in the epigas-trium and any irregularity or tenderness noted. Anenlarged caudate lobe, as in the Budd–Chiari syndromeor with some cases of cirrhosis, may be palpated as anepigastric mass.

Pulsation of the liver, usually associated with tricus-pid valvular incompetence, is felt by manual palpationwith one hand behind the right lower ribs posteriorlyand the other anteriorly on the abdominal wall.

The upper edge is determined by fairly heavy percus-sion passing downwards from the nipple line. The loweredge is recognized by very light percussion passingupwards from the umbilicus towards the costal margin.Percussion is a valuable method of determining liversize and is the only clinical method of determining asmall liver.

The anterior liver span is obtained by measuring thevertical distance between the uppermost and lowermostpoints of hepatic dullness by percussion in the right mid-clavicular line. This is usually 12–15cm. Direct percus-sion is as accurate as ultrasound in estimating liver span[33].

Friction may be palpable and audible, usually due torecent biopsy, tumour or peri-hepatitis. The venous humof portal hypertension is audible between the umbilicusand the xiphisternum. An arterial murmur over the livermay indicate a primary liver cancer or acute alcoholichepatitis.

The gallbladder is palpable only when it is distended. Itis felt as a pear-shaped cystic mass usually about 7cmlong. In a thin person, the swelling can sometimes beseen through the anterior abdominal wall. It movesdownwards on inspiration and is mobile laterally butnot downwards. The swelling is dull to percussion anddirectly impinges on the parietal peritoneum, so that thecolon is rarely in front of it. Gallbladder dullness is con-tinuous with that of the liver.

Abdominal tenderness should be noted. Inflammationof the gallbladder causes a positive Murphy’s sign. This is

the inability to take a deep breath when the examiningfingers are hooked up below the liver edge. The inflamedgallbladder is then driven against the fingers and thepain causes the patient to catch their breath.

The enlarged gallbladder must be distinguished froma visceroptotic right kidney. This, however, is more mobile,can be displaced towards the pelvis and has the resonantcolon anteriorly. A regenerative or malignant nodule feelsmuch firmer.

Imaging. A plain film of the abdomen, including thediaphragms, may be used to assess liver size and in par-ticular to decide whether a palpable liver is due to actualenlargement or to downward displacement. On moder-ate inspiration the normal level of the diaphragm, on theright side, is opposite the 11th rib posteriorly and the 6thrib anteriorly.

Ultrasound, CT or MRI can also be used to study liversize, shape and content.

Hepatic morphology

Kiernan (1833) introduced the concept of hepatic lobulesas the basic architecture. He described circumscribedpyramidal lobules consisting of a central tributary of thehepatic vein and at the periphery a portal tract contain-ing the bile duct, portal vein radicle and hepatic arterybranch. Columns of liver cells and blood-containingsinusoids extend between these two systems.

Stereoscopic reconstructions and scanning electronmicroscopy have shown the human liver as columns ofliver cells radiating from a central vein, and interlaced inorderly fashion by sinusoids (fig. 1.9).

The liver tissue is pervaded by two systems of tunnels,the portal tracts and the hepatic central canals whichdovetail in such a way that they never touch each other;the terminal tunnels of the two systems are separated by about 0.5mm (fig. 1.10). As far as possible the twosystems of tunnels run in planes perpendicular to eachother. The sinusoids are irregularly disposed, normallyin a direction perpendicular to the lines connecting thecentral veins. The terminal branches of the portal veindischarge their blood into the sinusoids and the directionof flow is determined by the higher pressure in the portalvein than in the central vein.

The central hepatic canals contain radicles of the hepaticvein and their adventitia. They are surrounded by a lim-iting plate of liver cells.

The portal triads (syn. portal tracts, Glisson’s capsule)contain the portal vein radicle, the hepatic arteriole andbile duct with a few round cells and a little connectivetissue (fig. 1.11). They are surrounded by a limiting plateof liver cells. Portal dyads are as frequent as triads, withthe portal vein being the most frequently absent element.Within each linear centimetre of liver tissue obtained at

6 Chapter 1

Page 25: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

Anatomy and Function 7

Perisinusoidalspace of Disse

Sinusoids

Arterial capillary emptying intopara-portal sinusoid

Arterial capillary emptying intopara-portal sinusoid

Portalvein

Limitingplate

Peri-portalconnective

tissue

Central(hepatic)

veinsLymph vessel

Sub-lobularvein

Central (hepatic)veins

Intra-lobularcholangiole

Bile canaliculi on the surfaceof liver plates (not frequent)

Cholangioles inportal canals

Hepaticartery

Bileduct

Portalvein Limiting

platePortal tract

Inletvenules

Arterial capillaryemptying intointra-lobular sinusoid

Central(hepatic)

veins

Perisinusoidalspace of Disse

Central(hepatic)

veins

Fig. 1.9. The structure of the normal human liver.

P

P

P

P

H

H

P

Fig. 1.10. Normal hepatic histology. H, terminal hepatic vein; P, portal tract. (H & E, ¥60.)

Page 26: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

biopsy there are usually two interlobular bile ducts, twohepatic arteries and one portal vein per portal tract, withsix full portal triads [8].

The liver has to be divided functionally. Traditionally,the unit is based on a central hepatic vein and its sur-rounding liver cells. However, Rappaport [28] envisagesa series of functional acini, each centred on the portaltriad with its terminal branch of portal vein, hepaticartery and bile duct (zone 1) (figs 1.12, 1.13). These inter-digitate, mainly perpendicularly, with terminal hepaticveins of adjacent acini. The circulatory peripheries ofacini (adjacent to terminal hepatic veins) (zone 3) suffermost from injury whether viral, toxic or anoxic. Bridging

necrosis is located in this area. The regions closer to theaxis formed by afferent vessels and bile ducts survivelonger and may later form the core from which regenera-tion will proceed. The contribution of each acinar zone toliver cell regeneration depends on the acinar location ofdamage [28].

The liver cells (hepatocytes) comprise about 60% of theliver. They are polygonal and approximately 30mm indiameter. The nucleus is single or, less often, multipleand divides by mitosis. The lifespan of liver cells is about150 days in experimental animals. The hepatocyte hasthree surfaces: one facing the sinusoid and space ofDisse, the second facing the canaliculus and the thirdfacing neighbouring hepatocytes (fig. 1.14). There is nobasement membrane.

The sinusoids are lined by endothelial cells. Associ-ated with the sinusoids are the phagocytic cells of thereticulo-endothelial system (Kupffer cells), and thehepatic stellate cells, which have also been called fat-storing cells, Ito cells and lipocytes.

There are approximately 202¥103 cells in each mil-ligram of normal human liver, of which 171¥103 areparenchymal and 31¥103 littoral (sinusoidal, includingKupffer cells).

The space of Disse is a tissue space between hepatocytesand sinusoidal endothelial cells. The hepatic lymphaticsare found in the peri-portal connective tissue and arelined throughout by endothelium. Tissue fluid seepsthrough the endothelium into the lymph vessels.

The branch of the hepatic arteriole forms a plexusaround the bile ducts and supplies the structures in the portal tracts. It empties into the sinusoidal network at different levels. There are no direct hepatic arteriolar–portal venous anastomoses.

The excretory system of the liver begins with the bile

8 Chapter 1

P

A

B

Fig. 1.11. Normal portal tract. A, hepaticartery; B, bile duct; P, portal vein. (H & E.)

1 2 3Efferent vein

Simple acinus

Preterminalvessel

Terminalvessel

Fig. 1.12. The complex acinus according to Rappaport. Zone 1is adjacent to the entry (portal venous) system. Zone 3 isadjacent to the exit (hepatic venous) system.

Page 27: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

canaliculi (see figs 13.2, 13.3). These have no walls but aresimply grooves on the contact surfaces of liver cells (see fig. 13.1). Their surfaces are covered by microvilli.The plasma membrane is reinforced by micro-filamentsforming a supportive cytoskeleton (see fig. 13.2). Thecanalicular surface is sealed from the rest of the inter-cellular surface by junctional complexes including tightjunctions, gap junctions and desmosomes. The intra-lobular canalicular network drains into thin-walled terminal bile ducts or ductules (cholangioles, canals ofHering) lined with cuboidal epithelium. These terminatein larger (interlobular) bile ducts in the portal canals.They are classified into small (less than 100mm in diame-ter), medium (about 100mm) and large (more than 100mm).

Electron microscopy and hepato-cellularfunction (figs 1.14, 1.15)

The liver cell margin is straight except for a few anchor-

ing pegs (desmosomes). From it, equally sized andspaced microvilli project into the lumen of the bilecanaliculi. Along the sinusoidal border, irregularly sizedand spaced microvilli project into the peri-sinusoidaltissue space. The microvillous structure indicates activesecretion or absorption, mainly of fluid.

The nucleus has a double contour with pores allowinginterchange with the surrounding cytoplasm. Humanliver after puberty contains tetraploid nuclei and, atabout age 20, in addition, octoploid nuclei are found.Increased polyploidy has been regarded as precancer-ous. In the chromatin network one or more nucleoli areembedded.

The mitochondria also have a double membrane, theinner being invaginated to form grooves or cristae. Anenormous number of energy-providing processes takeplace within them, particularly those involving oxida-tive phosphorylation. They contain many enzymes, par-ticularly those of the citric acid cycle and those involvedin b-oxidation of fatty acids. They can transform energy

Anatomy and Function 9

THV

PS

PS

PS

LIVER

1

Fig. 1.13. Blood supply of the simple liver acinus, zonal arrangements of cells and the microcirculatory periphery. The acinusoccupies adjacent sectors of the neighbouring hexagonal fields. Zones 1, 2 and 3, respectively, represent areas supplied with blood offirst, second and third quality with regard to oxygen and nutrient content. These zones centre on the terminal afferent vascularbranches, bile ductules, lymph vessels and nerves (PS) and extend into the triangular portal field from which these branches cropout. Zone 3 is the microcirculatory periphery of the acinus since its cells are as remote from their own afferent vessels as from those ofadjacent acini. The peri-venular area is formed by the most peripheral portions of zone 3 of several adjacent acini. In injuryprogressing along this zone, the damaged area assumes the shape of a starfish (darker tint around a terminal hepatic venule, THV, inthe centre). 1–3, microcirculatory zones; 1¢–3¢, zones of neighbouring acinus [28].

Page 28: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

so released into adenosine diphosphate (ADP). Haemsynthesis occurs here.

The rough endoplasmic reticulum (RER) is seen as lamel-lar structures lined by ribosomes. These are responsible for basophilia under light microscopy. They synthesizespecific proteins, particularly albumin, those used inblood coagulation and enzymes. They may adopt a helix arrangement, as polysomes, for co-ordination ofthis function. Glucose-6-phosphatase is synthesized.Triglycerides are synthesized from free fatty acids and complexed with protein to be secreted by exocytosis as lipoprotein. The RER may participate inglycogenesis.

The smooth endoplasmic reticulum (SER) forms tubulesand vesicles. It contains the microsomes. It is the site ofbilirubin conjugation and the detoxification of manydrugs and other foreign compounds (P450 systems).Steroids are synthesized, including cholesterol and theprimary bile acids, which are conjugated with the aminoacids glycine and taurine. The SER is increased byenzyme inducers such as phenobarbital.

Peroxisomes are versatile organelles, which have com-plex catabolic and biosynthetic roles, and are distri-buted near the SER and glycogen granules. Peroxisomalenzymes include simple oxidases, b-oxidation cycles, the

glyoxalate cycle, ether lipid synthesis, and cholesteroland dolichol biosynthesis. Several disorders of per-oxisomal function are recognized of which Zellweger syndrome is one [14]. Endotoxin severely damages peroxisomes [7].

The lysosomes are dense bodies adjacent to the bilecanaliculi. They contain many hydrolytic enzymeswhich, if released, could destroy the cell. They are proba-bly intra-cellular scavengers which destroy organelleswith shortened lifespans. They are the site of depositionof ferritin, lipofuscin, bile pigment and copper. Pinocyticvacuoles may be observed in them. Some peri-canalicular dense bodies are termed microbodies.

The Golgi apparatus consists of a system of particlesand vesicles again lying near the canaliculus. It may beregarded as a ‘packaging’ site before excretion into thebile. This entire group of lysosomes, microbodies andGolgi apparatus is a means of sequestering any materialwhich is ingested and has to be excreted, secreted orstored for metabolic processes in the cytoplasm. TheGolgi apparatus, lysosomes and canaliculi are concernedin cholestasis (Chapter 13).

The intervening cytoplasm contains granules of glycogen, lipid and fine fibrils.

The cytoskeleton supporting the hepatocyte consists

10 Chapter 1

Hepatic stellate cellEndothelial cell

Sinusoid

Space of Disse

Lysosome

Peroxisome

Vacuole

Nucleolus

Chromatin

Lipid

Roughendoplasmicreticulum

Smoothendoplasmicreticulum

Kupffer cell

Reticulin fibre

Cell membrane

Desmosome

Gap junction

Tight junction

Biliary canaliculus

Golgi apparatus

Mitochondrion

Glycogen

Fig. 1.14. The organelles of the liver cell.

Page 29: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

of microtubules, micro-filaments and intermediate filaments [12]. Microtubules contain tubulin and con-trol subcellular mobility, vesicle movement and plasmaprotein secretion. Micro-filaments are made up of actin,are contractile and are important for the integrity andmotility of the canaliculus and for bile flow. Intermediatefilaments are elongated branched filaments comprisingcytokeratins [40]. They extend from the plasma mem-brane to the peri-nuclear area and are fundamental forthe stability and spatial organization of the hepatocyte.

Sinusoidal cells

The sinusoidal cells (endothelial cells, Kupffer cells,hepatic stellate cells and pit cells) form a functional andhistological unit together with the sinusoidal aspect ofthe hepatocyte [34].

Endothelial cells line the sinusoids and have fenestraewhich provide a graded barrier between the sinusoidand space of Disse (fig. 1.16). The Kupffer cells areattached to the endothelium.

The hepatic stellate cells lie in the space of Dissebetween the hepatocytes and the endothelial cells (fig.1.17). Disse’s space contains tissue fluid which flows out-wards into lymphatics in the portal zones. When sinu-soidal pressure rises, lymph production in Disse’s spaceincreases and this plays a part in ascites formation wherethere is hepatic venous outflow obstruction.

Endothelial cells. These cells form a continuous lining tothe sinusoids. They differ from endothelial cells else-

Anatomy and Function 11

Fig. 1.15. Electron microscopic appearances of part of anormal human liver cell. G, glycogen granules; IC, inter-cellular space; L, lysosomes; M, mitochondria; Mv, microvilli inthe intra-cellular space; N, nucleus; Nu, nucleolus; R, roughendoplasmic reticulum. (Courtesy of Ms J. Lewin.)

Fig. 1.16. Scanning electron micrographof sinusoid showing fenestrae (F)grouped into sieve plates (S). D, space ofDisse; E, endothelial cell; M, microvilli; P,parenchymal cell. (Courtesy of ProfessorE. Wisse.)

Page 30: Diseases of the Liver and Biliary System · 2013-07-23 · Circulatory failure, 199 Hepatic changes in acute heart failure and shock, 199 Ischaemic hepatitis, 200 Post-operative jaundice,

where in not having a regular basal lamina. The endothe-lial cells act as a sieve between the sinusoid and space ofDisse, have specific and non-specific endocytotic activityand have a variety of receptors. Their capacity to act as asieve is due to fenestrae, around 0.15mm in diameter (fig.1.16). These make up 6–8% of the total endothelial cellsurface, and there are more in the centrilobular zone ofthe sinusoid than the peri-portal area. Extra-cellularmatrix affects their function.

Fenestrae are clustered into sieve plates, and act as a biofilter between sinusoidal blood and the plasmawithin the space of Disse. They have a dynamiccytoskeleton [6]. This maintains and regulates their size,which can be changed by many influences includingalcohol, nicotine, serotonin, endotoxin and partial hepa-tectomy. The fenestrae filter macro-molecules of differ-ing size. Particles >0.2mm diameter, which includeslarge triglyceride-rich parent chylomicrons, will notpass. Smaller triglyceride-depleted, cholesterol-rich andretinol-rich remnants can enter the space of Disse [15]. Inthis way the fenestrae have an important role in chylomi-cron and lipoprotein metabolism.

Endothelial cells have a high capacity for endocytosis(accounting for 45% of all pinocytotic vesicles in theliver) and are active in clearing macro-molecules andsmall particles from the circulation [35]. There is receptor-mediated endocytosis for several moleculesincluding transferrin, caeruloplasmin, modified highdensity lipoprotein (HDL) and low density lipoprotein(LDL), hepatic lipase and very low density lipoprotein(VLDL). Hyaluronan (a major polysaccharide from con-

nective tissue) is taken up and this provides a method forassessing hepatic endothelial cell capacity. Endothelialcells can also clear small particles (<0.1mm) from the cir-culation, as well as denatured collagen. Scanning elec-tron microscopy has shown a striking reduction in thenumber of fenestrae, particularly in zone 3 in alcoholicpatients, with formation of a basal lamina, which is alsotermed capillarization of the sinusoid [17].

Kupffer cells. These are highly mobile macrophagesattached to the endothelial lining of the sinusoid, par-ticularly in the peri-portal area. They stain with peroxi-dase. They have microvilli and intra-cytoplasmic-coatedvesicles and dense bodies which make up the lysosomalapparatus. They proliferate locally but under certain circumstances macrophages can immigrate from anextra-hepatic site. They are responsible for removing oldand damaged blood cells or cellular debris, also bac-teria, viruses, parasites and tumour cells. They do this by endocytosis (phagocytosis, pinocytosis), includingabsorptive (receptor-mediated) and fluid phase (non-receptor-mediated) mechanisms [39]. Several processesaid this, including cell surface Fc and complement recep-tors. Coating of the particle with plasma fibronectin oropsonin also facilitates phagocytosis, since Kupffer cellshave specific binding sites for fibronectin on the cellsurface. These cells also take up and process oxidizedLDL (thought to be atherogenic), and remove fibrin in disseminated intravascular coagulation. Alcoholreduces the phagocytic capacity.

Kupffer cells are activated by a wide range of agents,including endotoxin, sepsis, shock, interferon-g, arachi-

12 Chapter 1

Fig. 1.17. Transmission electronmicrograph of a hepatic stellate cell. Notethe characteristic fat droplets (F). C, bilecanaliculus; D, space of Disse; M,mitochondria; N, nucleus; P, parenchymalcell; S, lumen of sinusoid. (¥12000.)(Courtesy of Professor E. Wisse.)


Recommended